Approved drug dronedarone found to inhibit the proliferation of esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and contributing significantly to cancer-related mortality globally. Despite advancements in combination therapies, patient prognosis remains poor, highlighting an urgent need for novel treatment strategies.

Leave A Comment

Your email address will not be published. Required fields are marked *